NovaBridge Biosciences (NBP) Long-Term Investments (2020 - 2023)

NovaBridge Biosciences (NBP) has 4 years of Long-Term Investments data on file, last reported at $1.7 million in Q4 2023.

• Long-Term Investments for Q4 2023 came in at $1.7 million, down 61.31% year-over-year; the trailing twelve-month figure through Dec 2023 was $1.7 million (down 61.31% YoY), and the FY2022 annual result was $4.5 billion, up 7995.49% from the prior year.
• Long-Term Investments grew to $1.7 million in Q4 2023 per NBP's latest filing, from $1.6 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $55.1 billion in Q4 2021 and troughed at $40892.1 in Q4 2020.
• A 4-year average of $6.9 billion and a median of $18.4 million in 2022 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2021 and 2022: Long-Term Investments surged 134678182.77% in 2021, then slumped 99.99% in 2022.
• A 4-year view of Long-Term Investments shows it stood at $40892.1 in 2020, then surged by 134678182.77% to $55.1 billion in 2021, then tumbled by 99.99% to $4.3 million in 2022, then tumbled by 61.31% to $1.7 million in 2023.
• Business Quant data shows NBP's Long-Term Investments at $1.7 million in Q4 2023, $1.6 million in Q2 2023, and $4.3 million in Q4 2022.